Johnson M P, Nichols D E
Department of Pharmacology, Purdue University, West Lafayette, IN 47907.
Pharmacol Biochem Behav. 1990 May;36(1):105-9. doi: 10.1016/0091-3057(90)90133-3.
The optical isomers of fenfluramine and norfenfluramine were administered to rats to examine their relative potency for destruction of serotonin neurons. Rats were sacrificed one week following a single 10 mg/kg SC injection of one of the four compounds and monoamine and metabolite levels in the frontal cortex and hippocampus brain regions were examined by HPLC-EC techniques. In addition, [3H]-paroxetine binding to homogenates of these brain regions was determined. With the exception of hippocampal 5-HT levels following d-fenfluramine treatment, there was a decrease in all the serotonergic markers assayed, following treatment with the d-enantiomers of fenfluramine and norfenfluramine. No decrease in any serotonergic marker was seen at this dose following treatment with the l-enantiomers of fenfluramine or norfenfluramine. Also, none of the drug treatments resulted in a significant decrease in catecholamines or their metabolites. With all the serotonergic markers examined, d-norfenfluramine was found to cause a significantly greater decrease than d-fenfluramine. The significance of these results is discussed in terms of the hypothesis that the long-term serotonergic deficits observed with d-fenfluramine may result from its metabolite, d-norfenfluramine.
将芬氟拉明和去甲芬氟拉明的光学异构体给予大鼠,以研究它们对5-羟色胺能神经元破坏的相对效力。在单次皮下注射四种化合物之一(剂量为10mg/kg)一周后处死大鼠,并用高效液相色谱-电化学检测技术检测额叶皮质和海马脑区的单胺和代谢物水平。此外,还测定了[3H]-帕罗西汀与这些脑区匀浆的结合情况。除了d-芬氟拉明治疗后海马5-羟色胺水平外,用芬氟拉明和去甲芬氟拉明的d-对映体治疗后,所有检测的5-羟色胺能标记物均减少。用芬氟拉明或去甲芬氟拉明的l-对映体治疗后,在该剂量下未观察到任何5-羟色胺能标记物减少。而且,所有药物治疗均未导致儿茶酚胺及其代谢物显著减少。在所检测的所有5-羟色胺能标记物中,发现d-去甲芬氟拉明比d-芬氟拉明引起的减少更为显著。根据d-芬氟拉明长期观察到的5-羟色胺能缺陷可能由其代谢物d-去甲芬氟拉明引起这一假说,对这些结果的意义进行了讨论。